PHASE 2 OPEN-LABEL EXTENSION STUDY OF PATISIRAN, AN INVESTIGATIONAL RNAI THERAPEUTIC FOR THE TREATMENT OF FAMILIAL AMYLOID POLYNEUROPATHY

Adams David; Suhr Ole; Conceicao Isabel; Waddington-Cruz Marcia; Schmidt Hartmut; Buades Juan; Campistol Josep; Pouget Jean; Berk John; Coelho Teresa

首页> 外文期刊>Journal of Neurology, Neurosurgery and Psychiatry >PHASE 2 OPEN-LABEL EXTENSION STUDY OF PATISIRAN, AN INVESTIGATIONAL RNAI THERAPEUTIC FOR THE TREATMENT OF FAMILIAL AMYLOID POLYNEUROPATHY

【24h】

PHASE 2 OPEN-LABEL EXTENSION STUDY OF PATISIRAN, AN INVESTIGATIONAL RNAI THERAPEUTIC FOR THE TREATMENT OF FAMILIAL AMYLOID POLYNEUROPATHY

机译：帕西西兰（PATISIRAN）的2期开放式扩展研究，这是一种用于治疗家族性淀粉样变性神经病变的RNAi治疗药物

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Journal of Neurology, Neurosurgery and Psychiatry》 |2015年第11期|共1页
作者
Adams David; Suhr Ole; Conceicao Isabel; Waddington-Cruz Marcia; Schmidt Hartmut; Buades Juan; Campistol Josep; Pouget Jean; Berk John; Coelho Teresa;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类神经病学;
关键词

相似文献

外文文献
中文文献
专利

1. PHASE 2 OPEN-LABEL EXTENSION STUDY OF PATISIRAN, AN INVESTIGATIONAL RNAI THERAPEUTIC FOR THE TREATMENT OF FAMILIAL AMYLOID POLYNEUROPATHY [J] . Adams David, Suhr Ole, Conceicao Isabel, Journal of Neurology, Neurosurgery and Psychiatry . 2015,第11期

机译：帕西西兰（PATISIRAN）的2期开放式扩展研究，这是一种用于治疗家族性淀粉样变性神经病变的RNAi治疗药物
2. PHASE 2 OPEN-LABEL EXTENSION (OLE) STUDY OF PATISIRAN, AN INVESTIGATIONAL RNA INTERFERENCE (RNAI) THERAPEUTIC FOR THE TREATMENT OF HEREDITARY ATTR AMYLOIDOSIS WITH POLYNEUROPATHY [J] . Adams D., Coelho T., Conceicao E., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2017,第5期

机译：Patisiran的第2阶段开放标签延伸（OLE）研究，一种调查RNA干扰（RNAi）治疗遗传性遗传素邻近的遗传素
3. Phase 2 Open-Label Extension Study of Patisiran, an RNAi Therapeutic for the Treatment of Familial Amyloidotic Polyneuropathy [J] . Adams David, Suhr Ole, Coelho Teresa, Annals of neurology . 2014,第Suppla18期

机译：Patisiran，用于治疗家族性淀粉样变性多发性神经病的RNAi治疗药物的2期开放标签扩展研究
4. The First Transthyretin Familial Amyloid Polyneuropathy Gait Quantification Study - Preliminary Results [C] . Maria do Carmo Vilas-Boas, Ana Patricia Rocha, Hugo Miguel Pereira Choupina, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2017

机译：第一个Transthyretin家族淀粉样蛋白聚母步态量化研究 - 初步结果
5. Adenosine Triphosphate Binding Cassette Subfamily C Member 1 (ABCC1) Modulates Amyloid Precursor Protein (App) Processing: a Potential Therapeutic Target for the Treatment of Alzheimer’s Disease [D] . Jepsen, Wayne. 2021

机译：腺苷三磷酸结合盒子类C成员1（ABCC1）调节淀粉样蛋白前体蛋白（APP）处理：治疗阿尔茨海默病的潜在治疗靶标
6. Phase 2 open-label extention (OLE) study of patisiran an investigational siRNA agent for familial amyloidotic polyneuropathy (FAP) [O] . David Adams, Ole B Suhr, Isabel Conceicao, 2015

机译：patisiran的2期开放标签扩展（OLE）研究一种用于家族性淀粉样变性多发性神经病（FAP）的研究性siRNA药物
7. Phase 2 open-label extention (OLE) study of patisiran, an investigational siRNA agent for familial amyloidotic polyneuropathy (FAP) [O] . David Adams, Ole B Suhr, Isabel Conceicao, 2015

机译：patisiran的2期开放标签扩展（OLE）研究，一种用于家族性淀粉样变性多发性神经病（FAP）的研究性siRNA药物

PHASE 2 OPEN-LABEL EXTENSION STUDY OF PATISIRAN, AN INVESTIGATIONAL RNAI THERAPEUTIC FOR THE TREATMENT OF FAMILIAL AMYLOID POLYNEUROPATHY

著录项

引文网络

相似文献

相关主题

期刊订阅